Frontiers in Microbiology · 2022 · 18 citations · 37 references
Life SciencesMicrobiologyToxicologyAntimicrobial PharmacologyAntimicrobial ResistanceMedical MicrobiologyAntibiotic ResistanceAntimicrobial ToxicityBacterial BiofilmsBiofilm FormationBiofilm Formation In InfectionCombination Antimicrobial TherapyAnti-biofilm StrategiesAntibacterial PropertiesAntibacterial ToxicityCytotoxicity Assays
Staphylococcus aureus and Staphylococcus epidermidis are associated with life-threatening infections. Despite the best medical care, these infections frequently occur due to antibiotic resistance and the formation of biofilms of these two bacteria (i.e., clusters of bacteria embedded in a matrix). As a consequence, there is an urgent need for effective anti-biofilm treatments. Here, we describe the antibacterial properties of a combination treatment of diethyldithiocarbamate (DDC) and copper ions (Cu 2+ ) and their low toxicity in vitro and in vivo . The antibacterial activity of DDC and Cu 2+ was assessed in vitro against both planktonic and biofilm cultures of S. aureus and S. epidermidis using viability assays, microscopy, and attachment assays. Cytotoxicity of DDC and Cu 2+ (DDC-Cu 2+ ) was determined using a human fibroblast cell line. In vivo antimicrobial activity and toxicity were monitored in Galleria mellonella larvae. DDC-Cu 2+ concentrations of 8 μg/ml DDC and 32 μg/ml Cu 2+ resulted in over 80% MRSA and S. epidermidis biofilm killing, showed synergistic and additive effects in both planktonic and biofilm cultures of S. aureus and S. epidermidis , and synergized multiple antibiotics. DDC-Cu 2+ inhibited MRSA and S. epidermidis attachment and biofilm formation in the xCELLigence and Bioflux systems. In vitro and in vivo toxicity of DDC, Cu 2+ and DDC-Cu 2+ resulted in > 70% fibroblast viability and > 90% G. mellonella survival. Treatment with DDC-Cu 2+ significantly increased the survival of infected larvae (87% survival of infected, treated larvae vs . 47% survival of infected, untreated larvae, p < 0.001). Therefore, DDC-Cu 2+ is a promising new antimicrobial with activity against planktonic and biofilm cultures of S. epidermidis and S. aureus and low cytotoxicity in vitro . This gives us high confidence to progress to mammalian animal studies, testing the antimicrobial efficacy and safety of DDC-Cu 2+ .
37
Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove et al. · Clinical Infectious Diseases · 2011 · 4.2K citations · Full text